Stocks and Investing
Stocks and Investing
Fri, January 20, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, January 19, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Silvan Tuerkcan Maintained (TSHA) at Buy with Decreased Target to $6 on, Jan 19th, 2023
Silvan Tuerkcan of JMP Securities, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Buy with Decreased Target from $20 to $6 on, Jan 19th, 2023.
Silvan has made no other calls on TSHA in the last 4 months.
There are 6 other peers that have a rating on TSHA. Out of the 6 peers that are also analyzing TSHA, 1 agrees with Silvan's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $3 on, Wednesday, November 9th, 2022
These are the ratings of the 5 analyists that currently disagree with Silvan
- Yanan Zhu of "Wells Fargo" Maintained at Buy with Decreased Target to $10 on, Wednesday, January 4th, 2023
- Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $16 on, Wednesday, November 9th, 2022
- Gil Blum of "Needham" Maintained at Strong Buy with Decreased Target to $16 on, Wednesday, November 9th, 2022
- Whitney Ijem of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $16 on, Tuesday, November 8th, 2022
- Jack Allen of "Baird" Maintained at Buy with Decreased Target to $21 on, Wednesday, October 26th, 2022
Contributing Sources